Pharmac ApS: Financial statements 2025
CVR: 38532529
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Pharmac ApS (CVR 38532529) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 3,203,639 and a net result of DKK 678,530 compared with DKK 828,872 the year before. That is a decrease of 14.2% compared with the year before. Equity in the 2025 report amounted to DKK 5,514,286. The solvency ratio was 88.3%.
- Gross Profit
- DKK 3,203,639
- Profit/Loss
- DKK 678,530
- Equity
- DKK 5,514,286
- Total Assets
- DKK 6,245,189
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 3.2 mio. | 679 t. | 5.5 mio. | 0 |
| 2024 | - | 3.7 mio. | 829 t. | 4.8 mio. | 3 |
| 2023 | - | 2.9 mio. | 410 t. | 4 mio. | 2 |
| 2022 | - | 3.7 mio. | 964 t. | 3.6 mio. | 2 |
| 2021 | - | 3.4 mio. | 875 t. | 2.6 mio. | 2 |
Official annual report
How creditworthy is Pharmac ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Pharmac ApS has published its annual report for 2024. Gross profit came to DKK 3,735,340, and the net result was DKK 828,872.
About Pharmac ApS
Pharmac ApS is a Danish company of the type Anpartsselskab based in Lille Skensved, founded in 2017. The company is registered under the industry Anden teknisk rådgivning. The management consists of Mads Friis Sørensen. The company is owned by AC Holding, LS ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 3,203,639 and a net result of DKK 678,530 compared with DKK 828,872 the year before. Equity in the 2025 report amounted to DKK 5,514,286.